<DOC>
	<DOC>NCT02701231</DOC>
	<brief_summary>The purpose of this study is to determine whether Low-frequency Rotating Magnetic Therapy System is effective and safe in the treatment of advanced lung cancer.</brief_summary>
	<brief_title>Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer</brief_title>
	<detailed_description>The purpose of this study is to assess the efficacy and safety of the Low-frequency Rotating Magnetic Therapy System(with systemic anti-tumor therapy) compared to systemic anti-tumor therapy in patients suffering from advanced lung cancer.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Willing and able to give written informed consent Male or female aged 18 years and older Histologic diagnosis of nonsmall cell lung cancer (unable to receive surgery) or small cell lung cancer (limited stage or extensive stage) Eastern Cooperative Oncology Group (ECOG) performance status (PS) â‰¤ 3 going to receive systemic antitumor therapy Measurable disease based on RECIST 1.1 Adequate hematologic and organ function Currently participating and receiving study therapy in, or has participated in a study of an investigational agent and received study therapy or used an investigational device Unable to lie in bed With any metal implants in body Human immunodeficiency virus (HIV) Malignancies other than lung cancer within 5 years prior to randomization History or current evidence of any condition, therapy or laboratory abnormality that might confound the results of the trial or interfere with the subject's participation for the full duration of the trial Pregnant or breastfeeding, or expecting to conceive or father children within the projected duration of the trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>Low-frequency rotating magnetic therapy system</keyword>
	<keyword>systemic anti-tumor therapy</keyword>
</DOC>